MiMedx Group (MDXG) Tops Q4 EPS by 1c

Go back to MiMedx Group (MDXG) Tops Q4 EPS by 1c

MiMedx Group (MDXG) PT Raised to $15 at Needham & Company as Momentum Continues

February 27, 2015 8:34 AM EST

Needham & Company analyst Mike Matson reiterated a Strong Buy rating and boosted his price target on MiMedx Group (NASDAQ: MDXG) to $15.00 (from $13.00) following Q4 results.

Matson commented, "MDXG's 4Q14 revenue was consistent with its 1/12/15 preannouncement while EPS met consensus. Management maintained its previously... More